logo
Share SHARE
FONT-SIZE Plus   Neg

CTI BioPharma Gets $10 Mln Milestone Payment For TRISENOX From Teva

CTI BioPharma Corp. (CTIC) announced Thursday that it has received a $10 million milestone payment from Teva Pharmaceutical Industries Ltd. (TEVA) related to the achievement of sales milestones for TRISENOX (arsenic trioxide).

TRISENOX was acquired from CTI BioPharma by Cephalon, Inc., which was subsequently acquired by Teva.

The company noted that the milestone was paid pursuant to an acquisition agreement for TRISENOX entered into with Cephalon under which CTI BioPharma is eligible to receive up to an additional $60 million in payments upon achievement by Teva of specified sales and development milestones related to TRISENOX.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
KMG Chemicals Inc. (KMG) is likely to beat earnings per share or EPS estimates, when it reports first quarter results on December 11, after the bell. First quarter results of KMG are expected to benefit from the impact of Irma and Harvey, and early October fires in the West. Sysco Corp. is looking ahead to own 50 fully electric semi tracks to be launched by Tesla. The new electric tractors could run 500 miles on a single charging. The order from the food service distribution giant that owns more than 7000 trucks is worth up to $10 million. Patreon, the crowdfunding platform for artists, announced Wednesday a change in its payment structure that it says will help creators keep more money. Meanwhile, many are concerned that the change may discourage their patrons from pledging.
comments powered by Disqus
Follow RTT